These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7286035)

  • 1. A pharmacodynamic and pharmacokinetic comparison of pindolol 20 mg retard and a conventional tablet.
    Aellig WH; Narjes HH; Nüesch E; Oertle RJ; Devos JE; Pacha W
    Eur J Clin Pharmacol; 1981; 20(3):179-83. PubMed ID: 7286035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison of pindolol 30 mg retard and 15 mg normal tablets.
    Aellig WH; Nüesch E; Pacha W
    Eur J Clin Pharmacol; 1982; 21(6):451-5. PubMed ID: 7075650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the duration of action of pindolol and slow release oxprenolol in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Nov; 14(3):167-9. PubMed ID: 729611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified antihypertensive therapy with pindolol retard.
    Kiowski W; Stumpe KO; Bühler FR
    Eur J Clin Pharmacol; 1982; 21(6):445-9. PubMed ID: 7075649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity and duration of action of pindolol and alprenolol compared in healthy volunteers.
    Aellig WH
    Eur J Clin Pharmacol; 1978 Dec; 14(5):305-8. PubMed ID: 729623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopharmacological studies with pindolol following intravenous and oral administration].
    Aellig WH
    Adv Clin Pharmacol; 1976; 11():9-13. PubMed ID: 1032575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ergometric evaluation of the cardioprotective effect of pindolol in coronary disease. Comparison of 2 galenic forms].
    Mérier GR; Perrenoud JJ
    Schweiz Med Wochenschr; 1988 Jul; 118(26):1016-20. PubMed ID: 3413461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiments with pindolol (Visken) in healthy volunteers.
    Aellig WH
    Med J Aust; 1977 Sep; 2(SP2):8-11. PubMed ID: 927284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between plasma concentrations and cardiac beta-adrenoceptor blockade--a study with oral and intravenous bopindolol.
    Aellig WH; Nüesch E; Engel G; Grevel J; Niederberger W; Rosenthaler J
    Br J Clin Pharmacol; 1986 Jan; 21(1):45-51. PubMed ID: 2868747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. beta-Adrenoceptor blocking effects and pharmacokinetics of pindolol. A study in hypertensive Africans.
    Salako LA; Falase AO; Ragon A; Adio RA
    Eur J Clin Pharmacol; 1979 Jun; 15(5):299-304. PubMed ID: 37094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers.
    Aellig WH
    Br J Clin Pharmacol; 1976 Apr; 3(2):251-7. PubMed ID: 973959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma levels and pharmacological effects of metoprolol administered as controlled release (Durules) and ordinary tablets in healthy volunteers.
    Johnsson G; Jordö L; Lundborg P; Regårdh CG; Rönn O
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):292-7. PubMed ID: 7000717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the cardiovascular effects of pindolol in DOCA/saline hypertensive rats.
    Buckingham RE; Hamilton TC; Robson D
    Br J Pharmacol; 1977 Jul; 60(3):461-9. PubMed ID: 19118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.
    Jennings GL; Bobik A; Fagan ET; Korner PI
    Br J Clin Pharmacol; 1979 Mar; 7(3):245-56. PubMed ID: 427002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic and pharmacodynamic comparison of an osmotic release oral metoprolol tablet and the metoprolol conventional tablet.
    Feliciano NR; Bouvet AA; Redalieu E; Castellana J; Luders RC; Schwartz DJ; Shum L; Zak S; Arnold JD; Leese PT
    Am Heart J; 1990 Aug; 120(2):483-9. PubMed ID: 2382633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of propranolol and pindolol on plasma ANP levels in humans at rest and during exercise.
    Bouissou P; Galen FX; Richalet JP; Lartigue M; Devaux F; Dubray C; Atlan G
    Am J Physiol; 1989 Aug; 257(2 Pt 2):R259-64. PubMed ID: 2527473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multiple dose pharmacokinetic and pharmacodynamic evaluation of conventional and 19/285 Oros formulations of metoprolol in healthy volunteers.
    Grainger SL; John VA; Shotton PA; Smith SE
    Br J Clin Pharmacol; 1985; 19 Suppl 2(Suppl 2):239S-244S. PubMed ID: 4005129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.
    Tomlinson B; Cruickshank JM; Hayes Y; Renondin JC; Lui JB; Graham BR; Jones A; Lewis AD; Prichard BN
    Br J Clin Pharmacol; 1990 Nov; 30(5):665-72. PubMed ID: 1980200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
    Himori N; Ishimori T; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1977 Jan; 225(1):152-65. PubMed ID: 15525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.